Sandra Lockmer

Artiklar

Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;188(2):259-267
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy
Lockmer S; Ren W; Brodtkorb M; Ostenstad B; Wahlin BE; Pan-Hammarstrom Q; Kimby E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(33):JCO1800262-3323
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up
Lockmer S; Ostenstad B; Hagberg H; Holte H; Johansson A-S; Wahlin BE; Wader KF; Steen CB; Meyer P; Maisenholder M; Smedby KE; Brown P; Kimby E
Article: THE LANCET HAEMATOLOGY. 2018;5(8):e359-e367
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
Federico M; Caballero Barrigon MD; Marcheselli L; Tarantino V; Manni M; Sarkozy C; Alonso-Alvarez S; Wondergem M; Cartron G; Lopez-Guillermo A; Issa D; Morschhauser F; Alcoceba M; Kimby E; Rusconi C; Chamuleau M; Holte H; Lockmer S; Montoto S; da Silva MG; Aurer I; Zucca E; Paszkiewicz-Kozik E; Minoia C; Skrypets T; Blaker YN; Salles G; Coiffier B
Article: LEUKEMIA. 2015;29(3):668-676
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
Junlen HR; Peterson S; Kimby E; Lockmer S; Linden O; Nilsson-Ehle H; Erlanson M; Hagberg H; Radlund A; Hagberg O; Wahlin BE

Thesis / dissertation: 2020
Follicular lymphoma : clinical and biological factors associated with response to therapy and overall prognosis
Lockmer, Sandra Johanna Young
Letter: HAEMATOLOGICA. 2019;104(10):e460-e464
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
Steen CB; Leich E; Myklebust JH; Lockmer S; Wise JF; Wahlin BE; Ostenstad B; Liestol K; Kimby E; Rosenwald A; Smeland EB; Holte H; Lingjaerde OC; Brodtkorb M
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):759-760
Is Longer Progression-Free Survival a Goal Worth Pursuing in Follicular Lymphoma? Reply
Lockmer S; Ostenstad B; Hagberg H; Holte H; Wahlin BE; Wader KF; Smedby KE; Brown P; Kimby E

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2020
Läkarexamen, Karolinska Institutet, 2008